Last updated on December 2018

An Investigational Immunotherapy Study of Nivolumab With Standard of Care Therapy vs Standard of Care Therapy for First-Line Treatment of Colorectal Cancer That Has Spread


Brief description of study

This purpose of this study is to evaluate nivolumab (BMS-936558) in combination with standard of care (SOC) chemotherapy with bevacizumab for the treatment of first-line metastatic colorectal cancer (mCRC).

Clinical Study Identifier: NCT03414983

Find a site near you

Start Over

Local Institution

San Diego, CA United States
  Connect »

Local Institution

Santa Barbara, CA United States
  Connect »

Local Institution

Jacksonville, FL United States
  Connect »

Local Institution

Indianapolis, IN United States
  Connect »

Local Institution

Boston, MA United States
  Connect »

Local Institution

New York, NY United States
  Connect »

Local Institution

Chattanooga, TN United States
  Connect »

Broome Oncology

Johnson City, NY United States
  Connect »

Texas Oncology, P.A.

Bedford, TX United States
  Connect »

Texas Oncology-Tyler

Longview, TX United States
  Connect »

Illinois Cancer Specialists

Arlington Heights, IL United States
  Connect »

Cancer Centers of South Texas

San Antonio, TX United States
  Connect »

Virginia Cancer Center

Richmond, VA United States
  Connect »

University Of Wisconsin

Madison, WI United States
  Connect »

Tennessee Oncology, PLLC

Nashville, TN United States
  Connect »

Sanford Research

Sioux Falls, SD United States
  Connect »

Mayo Clinic

Rochester, MN United States
  Connect »

University Of Pennsylvania

Philadelphia, PA United States
  Connect »

Hosp. Univ. Puerta De Hierro

Majadahonda - Madrid, Spain
  Connect »

University of Colorado

Aurora, CO United States
  Connect »

Florida Cancer Specialists

Saint Petersburg, FL United States
  Connect »

Uab Comprehensive Cancer Center

Birmingham, AL United States
  Connect »

Yale Cancer Center

New Haven, CT United States
  Connect »

Allegheny Health Network

Pittsburgh, PA United States
  Connect »

Levine Cancer Institute

Charlotte, NC United States
  Connect »

Local Institution

Trois-Rivieres, QC Canada
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.